Amanote Research
Register
Sign In
Mineralocorticoids, Hypertension, and Cardiac Fibrosis.
Journal of Clinical Investigation
- United States
doi 10.1172/jci117269
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
June 1, 1994
Authors
M Young
M Fullerton
R Dilley
J Funder
Publisher
American Society for Clinical Investigation
Related search
Inhibition of Platelet Activation by Clopidogrel Prevents Hypertension-Induced Cardiac Inflammation and Fibrosis
Cardiovascular Drugs and Therapy
Medicine
Cardiovascular Medicine
Pharmacology
Cardiology
Chemokines and Cardiac Fibrosis
Frontiers in Bioscience - Scholar
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Nonproteolytic Activation of Prorenin Contributes to Development of Cardiac Fibrosis in Genetic Hypertension
Hypertension
Internal Medicine
The Predictive Role of Cardiac Fibrosis Markers in Progression of Coronary Heart Disease Associated With Cardiac Arrhythmias and Arterial Hypertension
MOJ Biology and Medicine
Cardiac Failure and Hypertension
Blood & Vessel
Pharmacological Inhibition of -Protein Kinase C Attenuates Cardiac Fibrosis and Dysfunction in Hypertension-Induced Heart Failure
Hypertension
Internal Medicine
Increased Expression of (Pro)renin Receptor Does Not Cause Hypertension or Cardiac and Renal Fibrosis in Mice
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
T Cell-Derived Interleukin-17a via an Interleukin-1 -Dependent Mechanism Mediates Cardiac Injury and Fibrosis in Hypertension
Hypertension
Internal Medicine
Pathophysiology and Therapeutic Potential of Cardiac Fibrosis
Inflammation and Regeneration
Allergy
Immunology
